Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Sandra Jovic"'
Autor:
Greta Rizzi, Deborah Pacifico, Serena Sabatini, Anna Maria Annoni, Federico Mele, Sandra Jovic, Luca Piccoli, Laurie Corna, Rebecca Amati, William Pertoldi, Maddalena Fiordelli, Federica Sallusto, Emiliano Albanese
Publikováno v:
Brain, Behavior, & Immunity - Health, Vol 35, Iss , Pp 100701- (2024)
Background: COVID-19 patients can report ‘brain fog’ and may exhibit cognitive symptoms for months after recovery (Cognitive COVID). However, evidence on whether and the extent to which SARS-CoV-2 infection impacts cognition irrespective of COVID
Externí odkaz:
https://doaj.org/article/c7b5e0e28dd94f4b8794c883b8bf631e
Autor:
Ricards Marcinkevics, Pamuditha N. Silva, Anna-Katharina Hankele, Charlyn Dörnte, Sarah Kadelka, Katharina Csik, Svenja Godbersen, Algera Goga, Lynn Hasenöhrl, Pascale Hirschi, Hasan Kabakci, Mary P. LaPierre, Johanna Mayrhofer, Alexandra C. Title, Xuan Shu, Nouell Baiioud, Sandra Bernal, Laura Dassisti, Mara D. Saenz-de-Juano, Meret Schmidhauser, Giulia Silvestrelli, Simon Z. Ulbrich, Thea J. Ulbrich, Tamara Wyss, Daniel J. Stekhoven, Faisal S. Al-Quaddoomi, Shuqing Yu, Mascha Binder, Christoph Schultheiβ, Claudia Zindel, Christoph Kolling, Jörg Goldhahn, Bahram Kasmapour Seighalani, Polina Zjablovskaja, Frank Hardung, Marc Schuster, Anne Richter, Yi-Ju Huang, Gereon Lauer, Herrad Baurmann, Jun Siong Low, Daniela Vaqueirinho, Sandra Jovic, Luca Piccoli, Sandra Ciesek, Julia E. Vogt, Federica Sallusto, Markus Stoffel, Susanne E. Ulbrich
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces B and T cell responses, contributing to virus neutralization. In a cohort of 2,911 young adults, we identified 65 individuals who had an asymptomatic or mildly symptomatic SARS-
Externí odkaz:
https://doaj.org/article/5ed868f2a518448cb1a26993a166470f
Autor:
Alberto J. Arribas, Sara Napoli, Luciano Cascione, Giulio Sartori, Laura Barnabei, Eugenio Gaudio, Chiara Tarantelli, Afua Adjeiwaa Mensah, Filippo Spriano, Antonella Zucchetto, Francesca M Rossi, Andrea Rinaldi, Manuel Castro de Moura, Sandra Jovic, Roberta Bordone-Pittau, Alessandra Di Veroli, Anastasios Stathis, Gabriele Cruciani, Georg Stussi, Valter Gattei, Jennifer R. Brown, Manel Esteller, Emanuele Zucca, Davide Rossi, Francesco Bertoni
Publikováno v:
Haematologica, Vol 107, Iss 11 (2022)
PI3Kδ inhibitors are active in patients with lymphoid neoplasms and a first series of them have been approved for the treatment of multiple types of B-cell lymphoid tumors, including marginal zone lymphoma (MZL). The identification of the mechanisms
Externí odkaz:
https://doaj.org/article/1745563a44104ecc87ba453e796f4738
Autor:
Luca Piccoli, Paolo Ferrari, Giovanni Piumatti, Sandra Jovic, Blanca Fernandez Rodriguez, Federico Mele, Isabella Giacchetto-Sasselli, Tatiana Terrot, Chiara Silacci-Fregni, Elisabetta Cameroni, Stefano Jaconi, Nicole Sprugasci, Istvan Bartha, Davide Corti, Mariagrazia Uguccioni, Antonio Lanzavecchia, Christian Garzoni, Olivier Giannini, Enos Bernasconi, Luigia Elzi, Emiliano Albanese, Federica Sallusto, Alessandro Ceschi
Publikováno v:
The Lancet Regional Health. Europe, Vol 1, Iss , Pp 100013- (2021)
Summary: Background: Hospital healthcare workers (HCW), in particular those involved in the clinical care of COVID-19 cases, are presumably exposed to a higher risk of acquiring the disease than the general population. Methods: Between April 16 and 3
Externí odkaz:
https://doaj.org/article/3f0f61474ddf45c9aea56d4e2054cf3f
Autor:
Quentin Philippot, Masato Ogishi, Jonathan Bohlen, Julia Puchan, Andrés Augusto Arias, Tina Nguyen, Marta Martin-Fernandez, Clement Conil, Darawan Rinchai, Mana Momenilandi, Seyed Alireza Mahdaviani, Mohammad Keramatipour, Jérémie Rosain, Rui Yang, Taushif Khan, Anna-Lena Neehus, Marie Materna, Ji Eun Han, Jessica Peel, Federico Mele, Marc Weisshaar, Sandra Jovic, Paul Bastard, Romain Lévy, Tom Le Voyer, Peng Zhang, Majistor Raj Luxman Maglorius Renkilaraj, Carlos A. Arango-Franco, Simon Pelham, Yoann Seeleuthner, Mathieu Pochon, Manar Mahmoud Ahmad Ata, Fatima Al Ali, Mélanie Migaud, Camille Soudée, Tatiana Kochetkov, Anne Molitor, Raphael Carapito, Seiamak Bahram, Bertrand Boisson, Claire Fieschi, Davood Mansouri, Nico Marr, Satoshi Okada, Mohammad Shahrooei, Nima Parvaneh, Zahra Chavoshzadeh, Aurélie Cobat, Dusan Bogunovic, Laurent Abel, Stuart G. Tangye, Cindy S. Ma, Vivien Béziat, Federica Sallusto, Stéphanie Boisson-Dupuis, Jacinta Bustamante, Jean-Laurent Casanova, Anne Puel
Publikováno v:
Science Immunology. 8
Patients with autosomal recessive (AR) IL-12p40 or IL-12Rβ1 deficiency display Mendelian susceptibility to mycobacterial disease (MSMD) due to impaired IFN-γ production and, less commonly, chronic mucocutaneous candidiasis (CMC) due to impaired IL-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f449e7f8285ce16560528d08288e0815
https://doi.org/10.1126/sciimmunol.abq5204
https://doi.org/10.1126/sciimmunol.abq5204
Autor:
Alberto J. Arribas, Sara Napoli, Luciano Cascione, Laura Barnabei, Giulio Sartori, Eleonora Cannas, Eugenio Gaudio, Chiara Tarantelli, Afua A. Mensah, Filippo Spriano, Antonella Zucchetto, Francesca M. Rossi, Andrea Rinaldi, Manuel Castro de Moura, Sandra Jovic, Roberta Bordone Pittau, Anastasios Stathis, Georg Stussi, Valter Gattei, Jennifer R. Brown, Manel Esteller, Emanuele Zucca, Davide Rossi, Francesco Bertoni
Publikováno v:
bioRxiv
BTK and PI3K inhibitors are among the drugs approved for the treatment of patients with lymphoid neoplasms. Although active, their ability to lead as single agents to long-lasting complete remission is rather limited especially in the lymphoma settin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::650dbcbfa343bf7d12bdb34071040c0f
https://europepmc.org/articles/PMC9881865/
https://europepmc.org/articles/PMC9881865/
Autor:
Mohamad N. Ali, Gopinath Kasetty, Malin Elvén, Saud Alyafei, Sandra Jovic, Arne Egesten, Heiko Herwald, Artur Schmidtchen, Praveen Papareddy
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Tissue factor pathway inhibitor-2 (TFPI-2) has previously been characterized as an endogenous anticoagulant. TFPI-2 is expressed in the vast majority of cells, mainly secreted into the extracellular matrix. Recently we reported that EDC34, a C-termin
Externí odkaz:
https://doaj.org/article/4a92078a50e8400d965a810c8c8adb7b
Autor:
null Mengyun Hu, null Samuele Notarbartolo, null Mathilde Foglierini, null Sandra Jovic, null Federico Mele, null David Jarrossay, null Antonio Lanzavecchia, null Antonino Cassotta, null Federica Sallusto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8111d71df2d83c27bd0e18806b0b1ba
https://doi.org/10.1002/eji.202250190/v2/response1
https://doi.org/10.1002/eji.202250190/v2/response1
Autor:
Alessandra Franzetti Pellanda, Jun Siong Low, Michela Perotti, Sandra Jovic, Laurent Perez, Rosalia Cacciatore, Christian Garzoni, Maira Biggiogero, Federico Mele, Josipa Jerak, Mathilde Foglierini, Antonio Lanzavecchia, Daniela Vaqueirinho, Federica Sallusto, Paolo Ferrari, David Jarrossay, Alessandro Ceschi, Tatiana Terrot, Antonino Cassotta
Publikováno v:
Science (New York, N.y.)
Probing CD4 T cell immunity to SARS-CoV-2 A better understanding of CD4 + T cell responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is crucial to the design of effective next-generation vaccines. Low et al. defined and estimate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::171bf8c7484196b6a8ddd9cf63f8191f
https://doi.org/10.1126/science.abg8985
https://doi.org/10.1126/science.abg8985
Autor:
Alberto J, Arribas, Sara, Napoli, Luciano, Cascione, Giulio, Sartori, Laura, Barnabei, Eugenio, Gaudio, Chiara, Tarantelli, Afua Adjeiwaa, Mensah, Filippo, Spriano, Antonella, Zucchetto, Francesca M, Rossi, Andrea, Rinaldi, Manuel, Castro de Moura, Sandra, Jovic, Roberta, Bordone-Pittau, Alessandra, Di Veroli, Anastasios, Stathis, Gabriele, Cruciani, Georg, Stussi, Valter, Gattei, Jennifer R, Brown, Manel, Esteller, Emanuele, Zucca, Davide, Rossi, Francesco, Bertoni
PI3Kδ inhibitors are active in patients with lymphoid neoplasms and a first series of them have been approved for the treatment of multiple types of B-cell lymphoid tumors, including marginal zone lymphoma (MZL). The identification of the mechanisms
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::63925be50b718d05168048be9f603556
https://hdl.handle.net/11391/1543676
https://hdl.handle.net/11391/1543676